Kaleido Biosciences, Inc.KLDOOTCMARKET
Loading
Operating Expenses Over TimeExpanding
Percentile Rank80
3Y CAGR+12.5%
5Y CAGR+55.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+12.5%/yr
Annual compound
5Y CAGR
+55.7%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
9.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2021 | $86.41M | +261.8% |
| 2020 | $23.88M | -72.4% |
| 2019 | $86.66M | +42.8% |
| 2018 | $60.68M | +124.5% |
| 2017 | $27.03M | +186.5% |
| 2016 | $9.44M | - |